Cargando…

Expanding the clinical phenotype of nuclear matrix protein 2 antibody-positive dermatomyositis

Detalles Bibliográficos
Autores principales:	Toker, Michelle, Nazarian, Roya S., Srivastava, Pooja, Amin, Bijal, Wu, Benedict
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982444/ https://www.ncbi.nlm.nih.gov/pubmed/36873052 http://dx.doi.org/10.1016/j.jdcr.2023.01.019

Ejemplares similares

My-Lupus: A case of anti-transcriptional intermediary factor 1-gamma antibody-positive dermatomyositis overlapping with discoid lupus erythematosus in an adult patient
por: Toker, Michelle, et al.
Publicado: (2023)

Did dupilumab unmask smoldering mycosis fungoides?
por: Toker, Michelle, et al.
Publicado: (2023)

Nuclear matrix protein 2 antibody-positive dermatomyositis associated with hepatocellular carcinoma
por: Ueda, Yoshitaka, et al.
Publicado: (2023)

Cutaneous metastasis of nuclear protein of the testis carcinoma: A new presentation of a rare entity
por: Toker, Michelle, et al.
Publicado: (2023)

COVID–19-associated diffuse dermal angiomatosis managed with pentoxifylline and topical timolol
por: Toker, Michelle, et al.
Publicado: (2023)

Clinically amyopathic dermatomyositis associated with anti-nuclear matrix protein 2 antibody
por: Abe, Saori, et al.
Publicado: (2021)

Anti-nuclear Matrix Protein 2 Antibody-positive Dermatomyositis Associated with Cervical Cancer Recurrence after 6 Years of Stable Disease
por: Suga, Takeshi, et al.
Publicado: (2022)

Thrombotic vasculopathy due to polymer coating emboli after an endovascular procedure
por: Nazarian, Roya S., et al.
Publicado: (2021)

Linear porokeratosis presenting in adulthood: A diagnostic challenge: A case report
por: Nazarian, Roya S, et al.
Publicado: (2020)

Anti-Ro52/Anti-nuclear Matrix Protein 2 Positive Clinically Amyopathic Dermatomyositis Presented Only With Interstitial Lung Disease
por: Skrimizeas, Stratos, et al.
Publicado: (2023)

A Continuous Increase in CXC-Motif Chemokine Ligand 10 in a Case of Anti-Nuclear Matrix Protein-2-Positive Juvenile Dermatomyositis
por: Nagamori, Tsunehisa, et al.
Publicado: (2022)

Calcinosis cutis causing cutaneous ulceration and secondary bacterial infection in a patient with antinuclear matrix protein 2 antibody–positive dermatomyositis
por: Takimiya, Ryuichi, et al.
Publicado: (2022)

Computed tomography-like magnetic resonance images based on T1 spoiled gradient-echo to detect calcinosis in a patient with anti-nuclear matrix protein 2 antibody-positive juvenile dermatomyositis
por: Fujita, Yuji, et al.
Publicado: (2022)

Juvenile Dermatomyositis—Clinical Phenotypes
por: Li, Danyang, et al.
Publicado: (2019)

Clinical Features of Dermatomyositis/Polymyositis with Anti-MDA5 Antibody Positivity
por: Chen, Qiuhe, et al.
Publicado: (2022)

Anti-nuclear matrix protein 2+ juvenile dermatomyositis with severe skin ulcer and infection: A case report and literature review
por: Wang, Ya-Ting, et al.
Publicado: (2022)

Painful perianal rash in an HIV-positive individual
por: Khanna, Urmi, et al.
Publicado: (2022)

Clinical and autoantibody phenotypes of juvenile dermatomyositis
por: Boyarchuk, Oksana, et al.
Publicado: (2022)

Anti-MDA5 antibody-positive dermatomyositis presenting as unilateral eyelid edema
por: Chen, Lauren, et al.
Publicado: (2020)

Myocardial involvement is not rare in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis/clinically amyopathic dermatomyositis: a retrospective study
por: Zhou, Shuang, et al.
Publicado: (2022)

Anti-transcription Intermediary Factor1γ-antibody-positive Dermatomyositis Complicated by Dysphagia
por: Kurushima, Shota, et al.
Publicado: (2017)

Analysis of human total antibody repertoires in TIF1γ autoantibody positive dermatomyositis
por: Megremis, Spyridon, et al.
Publicado: (2021)

Macrophage activation syndrome in MDA5 antibody-positive dermatomyositis and COVID-19 infection
por: Keshtkarjahromi, Marzieh, et al.
Publicado: (2021)

Clinical Characteristics of Anti-TIF-1γ Antibody-Positive Dermatomyositis Associated with Malignancy
por: Harada, Yumi, et al.
Publicado: (2022)

Cutaneous metastasis as the first sign of small-cell cancer: An unexpected presentation in a patient with concurrent prostate cancer
por: Kost, Yana, et al.
Publicado: (2022)

Dermatomyositis Sine Myositis with Membranoproliferative Glomerulonephritis
por: Owlia, Mohammad Bagher, et al.
Publicado: (2012)

A Matrix Prediction Model for the 6-Month Mortality Risk in Patients With Anti-Melanoma Differentiation-Associated Protein-5-Positive Dermatomyositis
por: Ouyang, Zhi-Ming, et al.
Publicado: (2022)

Dermatomyositis: Muscle Pathology According to Antibody Subtypes
por: Tanboon, Jantima, et al.
Publicado: (2022)

Anti-TIF1gamma Antibody-Positive Dermatomyositis Associated with Myelodysplastic Syndrome: Response to Treatment
por: Lerman, Irina, et al.
Publicado: (2019)

Management of MDA-5 antibody-positive dermatomyositis with interstitial lung disease—an Auckland case series
por: Dick, Michael, et al.
Publicado: (2021)

Cutaneous Features of Anti-MDA-5 Antibody-Positive Amyopathic Dermatomyositis in a Sudanese Patient
por: Alqahtani, Nouf, et al.
Publicado: (2021)

Anti-PL-7 antibody-positive dermatomyositis with progressive interstitial pneumonia complicated with tracheal ulcer
por: Sato, Shintaro, et al.
Publicado: (2021)

Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis
por: Ida, Tomoaki, et al.
Publicado: (2023)

Case of Anti-Small Ubiquitin-Like Modifier Activating Enzyme Antibody-Positive Dermatomyositis with Sarcoidosis
por: Sakano, Kei, et al.
Publicado: (2023)

Dermatomyositis with positive anti‐TIF1 gamma antibodies in an adult female: A case report
por: Adhikari, Krishna, et al.
Publicado: (2023)

Association between clinical phenotypes of dermatomyositis and polymyositis with myositis-specific antibodies and overlap systemic autoimmune diseases
por: Chiang, Hui-Ling, et al.
Publicado: (2021)

Slowly progressive interstitial lung disease preceding typical dermatomyositis symptoms in anti-melanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis
por: Isono, Taisuke, et al.
Publicado: (2021)

Dermatomyositis in a COVID-19 positive patient
por: Ho, Bao Vincent K., et al.
Publicado: (2021)

Editorial: Anti-MDA5-Positive Dermatomyositis
por: Gono, Takahisa, et al.
Publicado: (2022)

Morphological and biochemical analysis of anti-nuclear matrix protein antibodies in human sera.
por: Yu, E., et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_tt4hkmfj05dad874n3ec1kdi0n